NIM
IDXX icon

NEOS Investment Management’s Idexx Laboratories IDXX Stock Holding History

NEOS Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8M Buy
60,354
+6,721
+13% +$3.77M 0.12% 132
2026
Q1 		$30.1M Buy
53,633
+16,026
+43% +$10.3M 0.15% 114
2025
Q4 		$25.4M Buy
37,607
+7,556
+25% +$5.15M 0.15% 120
2025
Q3 		$19.2M Buy
30,051
+13,599
+83% +$8.25M 0.14% 129
2025
Q2 		$8.82M Buy
16,452
+6,481
+65% +$3.1M 0.11% 165
2025
Q1 		$4.19M Buy
9,971
+2,957
+42% +$1.28M 0.08% 222
2024
Q4 		$2.9M Buy
7,014
+904
+15% +$397K 0.07% 240
2024
Q3 		$3.09M Buy
6,110
+667
+12% +$324K 0.09% 197
2024
Q2 		$2.65M Buy
5,443
+1,228
+29% +$616K 0.11% 174
2024
Q1 		$2.28M Buy
4,215
+56
+1% +$30.6K 0.14% 136
2023
Q4 		$2.31M Buy
4,159
+304
+8% +$143K 0.22% 93
2023
Q3 		$1.69M Buy
+3,855
New +$1.92M 0.22% 96

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

NEOS Investment Management's IDXX Position: Q2 2026 in Review

NEOS Investment Management increased its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, buying an estimated $3.77M and bringing the position to 60,354 shares worth $31.8M. The position accounts for 0.12% of the portfolio, ranked #132.

NEOS Investment Management first reported a position in IDXX in Q3 2023 and has held it in 12 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NEOS Investment Management held 60,354 shares of Idexx Laboratories worth $31.8M as of Q2 2026.
  • NEOS Investment Management bought 6,721 Idexx Laboratories shares in Q2 2026, an estimated $3.77M.
  • Idexx Laboratories made up 0.12% of NEOS Investment Management's portfolio in Q2 2026, its #132 holding.
  • NEOS Investment Management first reported a position in Idexx Laboratories in Q3 2023 and has held it in 12 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.